Daniel Christian Christoph

4PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 28, 2026
Durvalumab Consolidation After Definitive Chemoradiotherapy in Patients with Unresectable Stage III Non-Small Cell Lung Cancer: A Real-World Cohort Analysis from the German Prospective, Observational CRISP Registry (AIO-TRK-0315).

|Mar 29, 2024
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy.

Joel Neal, Nick Pavlakis, Sang-We Kim

|Aug 12, 2023
Cancer-Associated Fibroblasts Influence Survival in Pleural Mesothelioma: Digital Gene Expression Analysis and Supervised Machine Learning Model.

Sabrina Borchert, Alexander Mathilakathu, Alina Nath

|Jul 21, 2021
Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinoma.

Martin Metzenmacher, Filippo Rizzo, Kato Kambartel

Pageof 1

Frequent Collaborators

1 joint publications

Martin Metzenmacher

1 joint publications

Jens Panse

1 joint publications

Mathias Hoiczyk

1 joint publications

Christopher Hoffmann